114 related articles for article (PubMed ID: 7303130)
1. [Interstitial therapy of tongue cancer with gold-198].
Slanina J
Strahlentherapie Sonderb; 1981; 76():80-3. PubMed ID: 7303130
[No Abstract] [Full Text] [Related]
2. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue.
Inoue T; Inoue T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169
[No Abstract] [Full Text] [Related]
3. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
[TBL] [Abstract][Full Text] [Related]
4. [Interstitial endophototherapy using 198-Au in the treatment of tumors of the tongue and floor of the mouth].
Popescu V; Bucur A; Iliescu I; Bratu V
Acta Stomatol Belg; 1975; 72(3):483-6. PubMed ID: 1062148
[No Abstract] [Full Text] [Related]
5. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue.
Inoue T; Inoue T; Yoshioka Y; Yoshida K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170
[No Abstract] [Full Text] [Related]
6. [Interstitial radiation therapy with 198Au after a radical operation for rectal cancer].
Brusilovskiĭ MI; Karlashenko NI
Med Radiol (Mosk); 1981 Jan; 26(1):15-8. PubMed ID: 6258001
[No Abstract] [Full Text] [Related]
7. [Quality control and radiation protection measures in interstitial radiotherapy].
Wannemacher M; Slanina J; Knüfermann H
Strahlenschutz Forsch Prax; 1986; 27():122-9. PubMed ID: 3754663
[No Abstract] [Full Text] [Related]
8. High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer.
Inoue T; Inoue T; Teshima T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():287-90. PubMed ID: 10895168
[No Abstract] [Full Text] [Related]
9. [The interstitial radiation therapy of cancer of the tongue and mucosa of the floor of the mouth].
Zamiatin OA; Vakhramova MP; Razorenova EV
Vopr Onkol; 1995; 41(2):112-4. PubMed ID: 7483404
[No Abstract] [Full Text] [Related]
10. Paediatric brachytherapy. I. The role of brachytherapy in the multidisciplinary therapy of localized cancers.
Plowman PN; Doughty D; Harnett AN
Br J Radiol; 1989 Mar; 62(735):218-22. PubMed ID: 2702378
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes of real-time intraoral sonography-guided implantation technique of 198Au grain brachytherapy for T1 and T2 tongue cancer.
Konishi M; Fujita M; Takeuchi Y; Kubo K; Imano N; Nishibuchi I; Murakami Y; Shimabukuro K; Wongratwanich P; Verdonschot RG; Kakimoto N; Nagata Y
J Radiat Res; 2021 Sep; 62(5):871-876. PubMed ID: 34196718
[TBL] [Abstract][Full Text] [Related]
12. [Dose, time and volume factors in interstitial therapy of tongue neoplasms with cf-252].
Vtiurin BM; Ivanov VN; Abdulkadyrov SA; Ivanova LF
Med Radiol (Mosk); 1982 Feb; 27(2):3-8. PubMed ID: 7070237
[No Abstract] [Full Text] [Related]
13. [Usefulness of a radiolucent spacer in radiation therapy for cancer of the tongue].
Niwa K; Morita K; Kanazawa H; Yokoi M
Gan No Rinsho; 1984 Dec; 30(15):1861-5. PubMed ID: 6441853
[TBL] [Abstract][Full Text] [Related]
14. [Transnasal permanent interstitial implantation for recurrent carcinoma of the nasopharynx].
Niwa K; Kanazawa H; Morita K
Rinsho Hoshasen; 1985 Mar; 30(3):435-7. PubMed ID: 4021140
[No Abstract] [Full Text] [Related]
15. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
[TBL] [Abstract][Full Text] [Related]
16. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
[TBL] [Abstract][Full Text] [Related]
17. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
18. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS
Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955
[TBL] [Abstract][Full Text] [Related]
19. [Iodine-125 as an adjunct in the treatment of squamous cell carcinomas of the tongue. An alternative to conventional interstitial radiotherapy using Au-198].
Stoll P; Schilli W; Knüfermann H; Wannenmacher M
Dtsch Z Mund Kiefer Gesichtschir; 1987; 11(1):28-32. PubMed ID: 3482513
[No Abstract] [Full Text] [Related]
20. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
